Stock BLRX BIOLINERX LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart BioLineRx Ltd.

Equities

BLRX

IL0011015182

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:30 2024-05-30 EDT 		5-day change 1st Jan Change
18 ILa +4.65% Intraday chart for BioLineRx Ltd. +11.80% -52.88%
05-30 BioLineRx Ltd Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization For Gene Therapy Applications in Sickle Cell Disease CI
05-28 Transcript : BioLineRx Ltd., Q1 2024 Earnings Call, May 28, 2024
7cb479dd332de7df0d142c4566.2XuX2EdLWx9QZIBbX2DOQqD9O0WfPVNTzdJQ_VR1m54.oUumlgQDa1ETLOFqBVK-cI23aQvSWSsJmaEpuTJNzdq_JNrsE3M8R2Q-5w~7efe202be03c4bf8db4baae26f11608c
  1. Stock Market
  2. Equities
  3. BLRX Stock
  4. Charts BioLineRx Ltd.
  5. News Chart